NovoCure Ltd Insider Trading for February 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NovoCure Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NovoCure Ltd for February 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2018 | NVCR | Novocure Ltd | Longsworth Todd Christopher | General Counsel | Option Exercise | M | 0.00 | 21,667 | 0 | 43,333 | |
| Feb 26 2018 | NVCR | Novocure Ltd | Longsworth Todd Christopher | General Counsel | Sell | S | 19.83 | 6,591 | 130,686 | 20,074 | 26.7 K to 20.1 K (-24.72 %) |
| Feb 26 2018 | NVCR | Novocure Ltd | Longsworth Todd Christopher | General Counsel | Buy | M | 21.55 | 21,667 | 466,924 | 26,665 | 5 K to 26.7 K (+433.51 %) |
| Feb 26 2018 | NVCR | Novocure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Option Exercise | M | 0.00 | 31,201 | 0 | 62,399 | |
| Feb 26 2018 | NVCR | Novocure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Sell | S | 19.83 | 8,458 | 167,705 | 96,830 | 105.3 K to 96.8 K (-8.03 %) |
| Feb 26 2018 | NVCR | Novocure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Buy | M | 21.55 | 31,201 | 672,382 | 105,288 | 74.1 K to 105.3 K (+42.11 %) |
| Feb 26 2018 | NVCR | Novocure Ltd | Danziger Asaf | Chief Executive Off ... | Option Exercise | M | 0.00 | 53,334 | 0 | 106,666 | |
| Feb 26 2018 | NVCR | Novocure Ltd | Danziger Asaf | Chief Executive Off ... | Buy | M | 21.55 | 53,334 | 1,149,348 | 410,124 | 356.8 K to 410.1 K (+14.95 %) |
| Feb 26 2018 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Option Exercise | M | 0.00 | 36,401 | 0 | 72,799 | |
| Feb 26 2018 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Buy | M | 21.55 | 36,401 | 784,442 | 39,582 | 3.2 K to 39.6 K (+1,144.33 %) |
| Feb 26 2018 | NVCR | Novocure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 0.00 | 43,334 | 0 | 86,666 | |
| Feb 26 2018 | NVCR | Novocure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 19.83 | 13,351 | 264,724 | 239,061 | 252.4 K to 239.1 K (-5.29 %) |
| Feb 26 2018 | NVCR | Novocure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 21.55 | 43,334 | 933,848 | 252,412 | 209.1 K to 252.4 K (+20.73 %) |
| Feb 08 2018 | NVCR | Novocure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Option Exercise | M | 0.23 | 50,000 | 11,500 | 74,087 | |
| Feb 08 2018 | NVCR | Novocure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Buy | M | 0.23 | 50,000 | 11,500 | 74,087 | 24.1 K to 74.1 K (+207.58 %) |